What Changed Since Our Last Report

The World Health Organization upgraded its risk assessment for the Congo Ebola outbreak to "very high" at the national level on Friday, May 22, according to PBS News and Politico EU. That's a step up from "high." Regional risk remains high. Global risk stays low.

WHO Director-General Tedros Adhanom Ghebreyesus said the numbers plainly: 82 confirmed cases in the Democratic Republic of Congo, seven confirmed deaths. He stated that "we know the epidemic in DRC is much larger." Almost 750 suspected cases and 177 suspected deaths are now on the books, according to PBS News.

The gap between confirmed and suspected cases has widened significantly.

The American Case — Details You Need

Here's what the CDC confirmed as of May 22: on May 17, an American who was providing patient care in DRC tested positive for Ebola Bundibugyo disease. The patient was NOT brought back to the United States. They were transported to Germany for treatment — the CDC notes Germany has prior experience with Ebola patients and the flight time is shorter.

High-risk contacts associated with that exposure were moved to Germany and the Czech Republic.

The CDC reported zero confirmed Ebola cases inside the United States as a result of this outbreak. The CDC describes overall risk to the American public as low.

The U.S. deliberately chose not to bring an infected person onto American soil.

New Geography: The Outbreak Is Spreading Inside Congo

The CDC flagged a critical development on May 22: a new confirmed case in Sud-Kivu Province. Previously, confirmed cases were limited to Ituri and Nord-Kivu provinces. The outbreak is finding new territory.

Uganda's situation, according to the CDC, remains at two confirmed cases and one death — both linked to travelers from DRC. No further spread has been reported there.

The Bundibugyo Strain

This isn't the Ebola strain most people think of. This outbreak is driven by the Bundibugyo virus, a rarer strain first identified in Uganda's Bundibugyo district in 2007, according to AP News. It has a lower fatality rate than the more infamous Zaire strain but presents its own treatment challenges.

The WHO announced it plans to test antiviral drug Obeldesivir — produced by American biopharmaceutical company Gilead — against the Bundibugyo virus, according to Politico EU. No specific timeline was given because trial logistics are still being negotiated.

Money Is Moving — But Is Anyone Coordinating?

The UN released $60 million from its Central Emergency Response Fund to accelerate the response, according to PBS News.

The U.S. separately pledged $23 million and said it would fund the establishment of up to 50 Ebola treatment clinics in affected regions of Congo and Uganda, according to PBS News.

Ugandan authorities told PBS News they were not aware of any treatment centers being set up by the U.S. That's either a coordination failure, a communication breakdown, or a pledge that hasn't materialized yet. The Trump administration has not clarified this discrepancy.

Trust Is the Real Bottleneck

A BBC report published Friday featured Patrick Faley, a Liberian Ebola survivor who volunteered during the 2014-2016 West Africa outbreak — the deadliest in history, which killed more than 11,000 people mostly in Guinea, Liberia, and Sierra Leone.

Faley's warning is straightforward: community trust determines whether containment works. Residents in Kinshasa are still packing markets, bars, and public transport despite international alarm, according to the New York Times.

WHO official Anne Ancia told reporters the rapidly rising suspected case numbers indicate surveillance is functioning. Surveillance alone, however, doesn't stop transmission.

What's Missing From the Coverage

Most outlets are treating this as a foreign-crisis story with a brief American angle. The coordination gaps deserve closer scrutiny. The U.S. pledged 50 treatment clinics — Uganda says it knows nothing about them. The WHO has no timeline for drug trials. The new province with confirmed cases barely made headlines.

The Trump administration's travel ban and screening measures have drawn criticism from Congolese health officials, per the New York Times. A more urgent question remains: is the $23 million actually reaching the ground, and are those clinics getting built?

Bottom Line

744 suspected cases. 177 suspected deaths. A new province infected. An American evacuated to Europe. Fifty promised clinics that Uganda hasn't heard about.

The outbreak isn't contained. The money is pledged but not clearly deployed.